143 related articles for article (PubMed ID: 38626072)
21. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
Tetzlaff MT; Curry JL; Ivan D; Wang WL; Torres-Cabala CA; Bassett RL; Valencia KM; McLemore MS; Ross MI; Prieto VG
Mod Pathol; 2013 Sep; 26(9):1153-60. PubMed ID: 23558574
[TBL] [Abstract][Full Text] [Related]
22. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
23. Invasive Cutaneous Melanoma: Evaluating the Prognostic Significance of Some Parameters Associated with Lymph Node Metastases.
Vița O; Jurescu A; Văduva A; Cornea R; Cornianu M; Tăban S; Szilagyi D; Micșescu C; Natarâș B; Dema A
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512052
[No Abstract] [Full Text] [Related]
24. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center.
Namikawa K; Aung PP; Gershenwald JE; Milton DR; Prieto VG
Cancer Med; 2018 Mar; 7(3):583-593. PubMed ID: 29464914
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomy.
Baker JJ; Meyers MO; Deal AM; Frank JF; Stitzenberg KB; Ollila DW
J Surg Oncol; 2015 May; 111(6):711-5. PubMed ID: 25663414
[TBL] [Abstract][Full Text] [Related]
26. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
27. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
[TBL] [Abstract][Full Text] [Related]
28. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas.
Fidanzi C; Bevilacqua M; D'Erme AM; Morganti R; Viacava P; Manzo Margiotta F; Romanelli M; Dini V; Janowska A; Bagnoni G
J Plast Reconstr Aesthet Surg; 2023 Aug; 83():215-220. PubMed ID: 37279633
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
[TBL] [Abstract][Full Text] [Related]
30. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma.
Mraz-Gernhard S; Sagebiel RW; Kashani-Sabet M; Miller JR; Leong SP
Arch Dermatol; 1998 Aug; 134(8):983-7. PubMed ID: 9722728
[TBL] [Abstract][Full Text] [Related]
31. The Relationship Between Epidermal Mitotic Density, Atypical Mitotic Figure Density, Breslow Depth, Ulceration, and Dermal Mitotic Rate in Cutaneous Melanoma: A Retrospective Cohort Study.
Marsch AF; McKee RM; Werbel T; Ruo B; Hinds BR
Int J Surg Pathol; 2021 Sep; 29(6):592-599. PubMed ID: 33624542
[TBL] [Abstract][Full Text] [Related]
32. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
[TBL] [Abstract][Full Text] [Related]
33. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
34. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study.
Litzner BR; Etufugh CN; Stepenaskie S; Hynan LS; Cockerell CJ
Am J Dermatopathol; 2012 Dec; 34(8):827-32. PubMed ID: 22878366
[TBL] [Abstract][Full Text] [Related]
35. Assessment of mitotic rate reporting in melanoma.
Burton AL; Egger ME; Gilbert JE; Stromberg AJ; Hagendoorn L; Martin RC; Scoggins CR; McMasters KM; Callender GG
Am J Surg; 2012 Dec; 204(6):969-74; discussion 974-5. PubMed ID: 23036603
[TBL] [Abstract][Full Text] [Related]
36. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
[TBL] [Abstract][Full Text] [Related]
37. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
38. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.
Sondak VK; Taylor JM; Sabel MS; Wang Y; Lowe L; Grover AC; Chang AE; Yahanda AM; Moon J; Johnson TM
Ann Surg Oncol; 2004 Mar; 11(3):247-58. PubMed ID: 14993019
[TBL] [Abstract][Full Text] [Related]
39. Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma.
Messeguer F; Agustí-Mejías A; Traves V; Requena C; Alegre V; Guillén C; Oliver V; Nagore E
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):436-41. PubMed ID: 22303982
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]